Table 4.
Clinical data and laboratory tests in patients of the bleeding group categorized according to changes in serum sodium concentratio
| Characteristics | Non-decreased (n = 58) | Decreased (n = 41) | p value |
|---|---|---|---|
| Age | 53.66 ± 10.14 | 58.54 ± 12.20 | 0.039 |
| Sex | 0.167 | ||
| Male (%) | 49 (84.5) | 30 (73.2) | |
| Female (%) | 9 (15.5) | 11(26.8) | |
| Etiology of cirrhosis | 0.507 | ||
| Alcoholics (%) | 35 (60.3) | 22 (53.7) | |
| Non-alcoholics (%) | 23 (39.7) | 19 (46.3) | |
| Infusion of albumin | 0.282 | ||
| Yes (%) | 20 (34.5) | 10 (24.4) | |
| No (%) | 38 (65.5) | 31 (75.6) | |
| Cumulative dose of Terlipressin (mg) | 14.21 ± 3.42 | 14.80 ± 3.39 | 0.391 |
| Amount of hydration (L) | 4.34 ± 1.77 | 4.64 ± 2.13 | 0.447 |
| Amount of sodium infused (mEq) | 341.25 ± 259.89 | 313.77 ± 321.40 | 0.652 |
| Total bilirubin (0 ~ 1.2 mg/dL) | 3.72 ± 5.37 | 2.44 ± 2.63 | 0.122 |
| Albumin (3.4 ~ 4.8 g/dL) | 2.60 ± 0.49 | 2.75 ± 0.55 | 0.162 |
| Creatinine (0.6 ~ 1.2 mg/dL) | 1.17 ± 0.51 | 1.03 ± 0.47 | 0.163 |
| Hemoglobin (13 ~ 17 g/dL) | 8.64 ± 2.46 | 9.12 ± 2.28 | 0.328 |
| *PT(0.8 ~ 1.2 *INR) | 1.79 ± 0.61 | 1.58 ± 0.41 | 0.057 |
| *MELD score | 16.17 ± 7.63 | 13.66 ± 6.97 | 0.098 |
| *MELD-Na | 17.50 ± 12.67 | 12.93 ± 9.31 | 0.052 |
| Child-Pugh score (6 ~ 18) | 8.60 ± 1.75 | 7.61 ± 2.23 | 0.015 |
| Initial sodium (135 ~ 145 mmol/L) | 134.22 ± 4.93 | 137.91 ± 3.46 | 0.000 |
| Lowest sodium (135 ~ 145 mmol/L) | 133.21 ± 5.14 | 128.90 ± 5.20 | 0.000 |
*PT, Prothrombin time; INR, International normalized ratio; MELD, Model for end-stage liver disease.